October 28, 2016 7:51 PM ET


Company Overview of TorreyPines Therapeutics, Inc.

Company Overview

As of September 29, 2009, TorreyPines Therapeutics, Inc. was acquired by Raptor Pharmaceuticals Corp., in a reverse merger transaction. TorreyPines Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of small molecule compounds in the United States. The company’s products under development include Tezampanel, which has completed Phase II clinical trial for the treatment of migraine; NGX426, an oral prodrug of tezampanel, which has completed Phase I clinical trial for the treatment of migraine and neuropathic pain; and NGX267, a Phase II clinical trial product for the treatment of xerostomia. It also develops a Gamma-secretase modulator drug discovery pro...

11085 North Torrey Pines Road

Suite 300

La Jolla, CA 92037

United States

10 Employees





Key Executives for TorreyPines Therapeutics, Inc.

TorreyPines Therapeutics, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TorreyPines Therapeutics, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.